Evidence map›Paper›PMID 36973247›Full record

ArticleNature communications2023

Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England.

Vahé Nafilyan, Charlotte R Bermingham, Isobel L Ward, Jasper Morgan, Francesco Zaccardi, Kamlesh Khunti, Julie Stanborough, Amitava Banerjee, James C Doidge

Open access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Response to the letter to the editor by J. Aarstad.European journal of epidemiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Vahé Nafilyan *Data and Analysis for Social Care and Health, Office for National Statistics, Newport, NP10 8XG, UK. vahe.nafilyan@ons.gov.uk.ORCID 0000-0003-0160-217X
Charlotte R Bermingham *Data and Analysis for Social Care and Health, Office for National Statistics, Newport, NP10 8XG, UK. charlotte.bermingham@ons.gov.uk.ORCID 0000-0003-3260-846X
Isobel L WardData and Analysis for Social Care and Health, Office for National Statistics, Newport, NP10 8XG, UK.
Jasper MorganData and Analysis for Social Care and Health, Office for National Statistics, Newport, NP10 8XG, UK.ORCID 0000-0002-7688-3554
Francesco ZaccardiReal World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.
Kamlesh KhuntiReal World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, UK.ORCID 0000-0003-2343-7099
Julie StanboroughData and Analysis for Social Care and Health, Office for National Statistics, Newport, NP10 8XG, UK.
Amitava BanerjeeInstitute of Health Informatics, University College London, London, NW1 2DA, UK.ORCID 0000-0001-8741-3411
James C DoidgeDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-3674-3100
Office for National Statistics · GBUniversity of Leicester · GBLondon School of Hygiene & Tropical Medicine · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies have reported associations between COVID-19 vaccination and risk of cardiac diseases, especially in young people; the impact on mortality, however, remains unclear. We use national, linked electronic health data in England to assess the impact of COVID-19 vaccination and positive SARS-CoV-2 tests on the risk of cardiac and all-cause mortality in young people (12 to 29 years) using a self-controlled case series design. Here, we show there is no significant increase in cardiac or all-cause mortality in the 12 weeks following COVID-19 vaccination compared to more than 12 weeks after any dose. However, we find an increase in cardiac death in women after a first dose of non mRNA vaccines. A positive SARS-CoV-2 test is associated with increased cardiac and all-cause mortality among people vaccinated or unvaccinated at time of testing.

Indexed as

Cause of DeathCOVID-19COVID-19 TestingCOVID-19 VaccinesSARS-CoV-2VaccinationAdolescentAdultAge FactorsChildElectronic Health RecordsEnglandFemaleHeart DiseasesHospitalizationHumansCOVID-19 VaccinesmRNA Vaccines

Identifiers

PMID36973247
PMCPMC10043280
OpenAlexW4361007103

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read46
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.